MAINTAINED VIRAL SUPPRESSION AND EXCELLENT SAFETY PROFILE OF ENTECAVIR MONOTHERAPY IN 418 NUC-NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A 4-YEAR FIELD PRACTICE, MULTICENTER STUDY

Angela Testa7, Pasquale Narciso7, Giorgio Antonucci7, Maria Vinci8, Giovambattista Pinzello8, Erika Fatta9, Silvia Fargion9, Paolo Del Poggio10, Barbara Coco11, Maurizia R. Brunetto11, Marco Andreoletti12, Agostino Colli12, Massimo Fasano14, Teresa Santantonio13, Guido Colloredo15, Luisa Pasulo16, Stefano Fagiuoli16, Alberto Eraldo Colombo17, Giorgio Bellati17, Francesco Fumagalli Maldini18, Maria Milanese18, Massimo Pozzi19, Natalia M. Terreni20, Giancarlo Spinzi20, Michela Quagliuolo21, Mauro Borzio21, Giovanna Lunghi22, Massimo Colombo1 Maintained viral suppression and excellent safety profile of entecavir monotherapy in 418 NUCnaive patients with chronic hepatitis B : a 4-year field practice, multicenter study